Christopher R. Fenimore - 08 Apr 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Controller
Signature
/s/**Christopher R. Fenimore
Issuer symbol
REGN
Transactions as of
08 Apr 2022
Transactions value $
-$1,413,652
Form type
4
Filing time
11 Apr 2022, 16:40:03 UTC
Previous filing
01 Apr 2022
Next filing
05 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1.36M +2.45K +9.89% $555.67 27.2K 08 Apr 2022 Direct
transaction REGN Common Stock Tax liability -$1.59M -2.16K -7.92% $736.21 25.1K 08 Apr 2022 Direct
transaction REGN Common Stock Options Exercise $1.35M +5K +19.95% $270.43 30.1K 08 Apr 2022 Direct
transaction REGN Common Stock Tax liability -$2.54M -3.45K -11.48% $736.21 26.6K 08 Apr 2022 Direct
holding REGN Common Stock 1.78K 08 Apr 2022 2021 GRAT
holding REGN Common Stock 1.46K 08 Apr 2022 By 401(k) Plan
holding REGN Common Stock 1.9K 08 Apr 2022 By Trust F1
holding REGN Common Stock 1.35K 08 Apr 2022 by 2018 GRAT
holding REGN Common Stock 25 08 Apr 2022 by Trust for Daugh
holding REGN Common Stock 25 08 Apr 2022 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -5K -50% $0.00 5K 08 Apr 2022 Common Stock 5K $270.43 Direct F2
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.45K -19.68% $0.00 10K 08 Apr 2022 Common Stock 2.45K $555.67 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.